pharmaphorum8 天
GSK’s Relvar Ellipta comes out on top in real world study
Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...
pharmaphorum4 天
GSK’s Relvar Ellipta comes out on top in real world study
Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...